GANX
Gain Therapeutics Inc.
$1.83
-$0.02(-1.08%)
42
Overall
40
Value
45
Tech
--
Quality
Market Cap
$74.41M
Volume
548.95K
52W Range
$1.41 - $4.34
Target Price
$7.60
EPS Estimates Overview
| Current Quarter | $-0.13 | Next Quarter | $-0.13 |
| Current Year | $-0.54 | Next Year | $-0.62 |
| QoQ Growth | +0.0% | YoY Growth | -14.8% |
| 3Y EPS CAGR | +13.4% | Target Price | $7.60 |
| Consensus | Buy | Upside | +315.3% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | GANX | $1.83 | -1.1% | 548.95K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |